reprise d’une provision à la suite d’une révision par Novartis des programmes de rabais accordés aux agences nationales de santé des Etats-Unis.
1 Full-year net sales in 2008 include a one-time contribution of USD 104 million in the second quarter of 2008. These brand-specific provision reversals were made following a Novartis review of accounting for rebate programs to US government health agencies.
